Home › Funds › AJU IB Investment Co., Ltd. › KYMR
AJU IB Investment Co., Ltd. position in KYMR
KYMERA THERAPEUTICS INC · Health Care
AJU IB Investment Co., Ltd. reported holding 19,648 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q1 2026 13F filing — a position valued at US$1.6M, representing 5.36% of its reported portfolio and ranking #2 among its reported holdings. AJU IB Investment Co., Ltd. has disclosed KYMR holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How AJU IB Investment Co., Ltd.'s KYMR position evolved
AJU IB Investment Co., Ltd. first disclosed a stake in KYMR in Q4 2024 at 457,059 shares (US$18.4M). The position peaked in Q3 2025 at 457,059 shares, worth US$25.9M. Across 6 filings, AJU IB Investment Co., Ltd. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q1 2026) shows 19,648 shares valued at US$1.6M. Notable position changes include a 96% trim in Q4 2025 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 457.06K | $18.39M | New |
| Q1 2025 | 457.06K | $12.51M | Hold |
| Q2 2025 | 457.06K | $19.95M | Hold |
| Q3 2025 | 457.06K | $25.86M | Hold |
| Q4 2025 | 19.65K | $1.53M | Reduce |
| Q1 2026 | 19.65K | $1.64M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M sh · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- BVF INC/IL 3.87M sh · $444.01M · Q2 2026
- Siren, L.L.C. 2.94M sh · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K sh · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K sh · $88.54M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K sh · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K sh · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K sh · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
More on AJU IB Investment Co., Ltd.
FAQ
How long has AJU IB Investment Co., Ltd. held KYMR?
AJU IB Investment Co., Ltd. has disclosed KYMR holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is AJU IB Investment Co., Ltd.'s current position in KYMR?
As of Q1 2026, AJU IB Investment Co., Ltd. holds 19.65K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $1.64M, representing 5.36% of its reported portfolio and ranking #2.
Has AJU IB Investment Co., Ltd. been buying or selling KYMR?
In the latest 13F filing (Q1 2026), AJU IB Investment Co., Ltd. held unchanged its position in KYMR. The position peaked in Q3 2025 at 457.06K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.